State Street Corp Lucid Diagnostics Inc. Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, State Street Corp holds 26,981 shares of LUCD stock, worth $21,045. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,981
Previous 18,428
46.41%
Holding current value
$21,045
Previous $14,000
57.14%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding LUCD
# of Institutions
36Shares Held
2.07MCall Options Held
0Put Options Held
0-
Luminus Management LLC Houston, TX726KShares$566,1430.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA561KShares$437,5130.0% of portfolio
-
Geode Capital Management, LLC Boston, MA204KShares$159,3960.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT126KShares$98,5620.01% of portfolio
-
Ayrton Capital LLC Westport, CT73.9KShares$57,6473.26% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $30.1M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...